Many structures that are present, often transiently, in the head of extant vertebrate embryos appear to be segmentally organized. These include the brain, particularly the hindbrain (e.g., rhombomeres), and adjacent axial structures such as paraxial mesoderm (e.g., somites, somitomeres) and neural crest cells. Also present in the head are additional sets of serially arranged structures that develop in more ventral and lateral locations. Examples of these are epibranchial placodes, aortic arches, and pharyngeal pouches. All these embryonic structures are frequently used both individually and collectively as characters to assist in defining homologies. New cell labeling and identification methods are providing detailed accounts of cell movements and tissue lineages that reveal a range of disparate behaviors not previously appreciated. The well-known migrations of neural crest cells bring all but the neurogenic members of this mesenchymal population form dorsal, axial locations into ventral and rostral locations where they largely surround the pharynx, stomodeum, and prosencephalon. Equally dramatic movements of neural plate cells, myoblasts, angioblasts, and placode-derived cells have recently been documented. These movements may occur in concert with those of other nearby tissues (e.g., branchiomeric myoblasts, neural crest cells, and surface ectoderm) or may be independent (e.g., placodal neuroblasts). Migrating cells may be clustered and follow definable pathways towards their destination (e.g., neural crest cells), or they may be solitary and wander invasively without a prespecified destination (e.g., angioblasts). These extensive morphogenetic movements bring cells into contact with a greater variety of other tissues and matrix environments than has heretofore been recognized. Moreover, because of these rearrangements, the cells present in a particular location, such as a branchial arch, may trace their ancestry to many axial levels, which complicates the analyses of segmental relations. Comparative morphological studies of craniofacial development have recently been augmented by descriptions of the sites and times of expression of many matrix components, growth factors and their receptors, and regulatory genes. Particularly important has been the discovery of a network of genes called the homeobox family. These genes are similar in their sequence and their organization along a chromosome to genes that establish the spatial identity of prospective body parts in drosophila. The combination of cellular and molecular descriptive studies of vertebrate craniofacial development provide exciting opportunities to catalogue patterns of gene expression and morphogenesis during the gastrula, neurula, and early organogenesis stages. Moreover, such data form the basis for proposing and then testing hypotheses about the mechanisms controlling cell movements, tissue formation, and the assembly of functionally integrated sets of structures. Our understanding of these mechanisms is far less complete. Examples are presented using methods of experimental embryology applied to tissues and to genes. These include studies in which tissues are extirpated or gene expression prevented, and experiments in which a spatial mismatch is created either by heterotopic grafts of embryonic tissues or by linking a gene to a promoter that alters its sites of expression. During craniofacial development, genes, cells, and tissues develop in a hierarchical manner, spatially as well as temporally. It is also evident that the traditional view of embryonic development, with focus on qualitative structures and relations, is inadequate to explain the dynamic nature of most morphogenetic processes. Only as more quantitative descriptors of developmental mechanisms and their outcomes become available will the data provide embryologists and systematists the opportunity to understand how developmental processes effect ontogenetic as well as evolutionary changes in vertebrate craniofacial morphology.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.